{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T03:26:32Z","timestamp":1783999592224,"version":"3.55.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T00:00:00Z","timestamp":1571961600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T00:00:00Z","timestamp":1571961600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s11606-019-05477-7","type":"journal-article","created":{"date-parts":[[2019,10,26]],"date-time":"2019-10-26T00:16:04Z","timestamp":1572048964000},"page":"865-873","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Measurement and Management of QT Interval Prolongation for General Physicians"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0301-2835","authenticated-orcid":false,"given":"Praveen","family":"Indraratna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Tardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline","family":"Delves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Szirt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,25]]},"reference":[{"key":"5477_CR1","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/pace.13292","volume":"41","author":"N Zhang","year":"2018","unstructured":"Zhang N, Gong M, Tse G, et al. Prolonged corrected QT interval in predicting atrial fibrillation: A systematic review and meta-analysis. Pacing Clin Electrophysiol 2018;41:321-7.","journal-title":"Pacing Clin Electrophysiol"},{"key":"5477_CR2","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.cpcardiol.2018.04.002","volume":"44","author":"SR Shah","year":"2019","unstructured":"Shah SR, Park K, Alweis R., Long QT Syndrome: A Comprehensive Review of the Literature and Current Evidence. Curr Probl Cardiol 2019;44:92-106.","journal-title":"Curr Probl Cardiol"},{"key":"5477_CR3","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1161\/CIRCULATIONAHA.106.661082","volume":"115","author":"NW Taggart","year":"2007","unstructured":"Taggart NW, Haglund CM, Tester DJ, Ackerman MJ. Diagnostic miscues in congenital long-QT syndrome. Circulation 2007;115:2613-20.","journal-title":"Circulation"},{"key":"5477_CR4","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1161\/CIRCEP.112.976803","volume":"6","author":"A Garg","year":"2013","unstructured":"Garg A, Lehmann MH. Prolonged QT interval diagnosis suppression by a widely used computerized ECG analysis system. Circ Arrhythm Electrophysiol 2013;6:76-83.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"5477_CR5","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1080\/AC.70.2.3073513","volume":"70","author":"S Talebi","year":"2015","unstructured":"Talebi S, Azhir A, Zuber S, et al. Underestimated and unreported prolonged QTc by automated ECG analysis in patients on methadone: can we rely on computer reading? Acta Cardiol 2015;70:211-6.","journal-title":"Acta Cardiol"},{"key":"5477_CR6","doi-asserted-by":"publisher","first-page":"884","DOI":"10.3109\/15563650903333820","volume":"47","author":"GK Isbister","year":"2009","unstructured":"Isbister GK, Calver L, Van Gorp F, Stokes B, Page CB. Inter-rater reliability of manual QT measurement and prediction of abnormal QT,HR pairs. Clin Toxicol (Phila) 2009;47:884-8.","journal-title":"Clin Toxicol (Phila)"},{"key":"5477_CR7","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.hrthm.2005.02.011","volume":"2","author":"S Viskin","year":"2005","unstructured":"Viskin S, Rosovski U, Sands AJ, et al. Inaccurate electrocardiographic interpretation of long QT: the majority of physicians cannot recognize a long QT when they see one. Heart Rhythm 2005;2:569-74.","journal-title":"Heart Rhythm"},{"key":"5477_CR8","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.ihj.2012.07.023","volume":"64","author":"V Salvi","year":"2012","unstructured":"Salvi V, Karnad DR, Kerkar V, et al. Choice of an alternative lead for QT interval measurement in serial ECGs when Lead II is not suitable for analysis. Indian Heart J 2012;64:535-40.","journal-title":"Indian Heart J"},{"key":"5477_CR9","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1161\/CIRCULATIONAHA.109.192704","volume":"121","author":"BJ Drew","year":"2010","unstructured":"Drew BJ, Ackerman MJ, Funk M, et al. Prevention of Torsade de Pointes in Hospital Settings: A Scientific Statement From the American Heart Association and the American College of Cardiology FoundationEndorsed by the American Association of Critical-Care Nurses and the International Society for Computerized Electrocardiology. Circulation 2010;121:1047-60.","journal-title":"Circulation"},{"key":"5477_CR10","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.hrthm.2008.03.037","volume":"5","author":"PG Postema","year":"2008","unstructured":"Postema PG, De Jong JS, Van der Bilt IA, Wilde AA. Accurate electrocardiographic assessment of the QT interval: teach the tangent. Heart Rhythm 2008;5:1015-8.","journal-title":"Heart Rhythm"},{"key":"5477_CR11","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1111\/acem.12752","volume":"22","author":"I Berling","year":"2015","unstructured":"Berling I, Isbister GK. The Half RR Rule: A Poor Rule of Thumb and Not a Risk Assessment Tool for QT Interval Prolongation. Acad Emerg Med 2015;22:1139-44.","journal-title":"Acad Emerg Med"},{"key":"5477_CR12","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/0002-9149(92)90562-D","volume":"70","author":"A Sagie","year":"1992","unstructured":"Sagie A, Larson MG, Goldberg RJ, Bengtson JR, Levy D. An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study). Am J Cardiol 1992;70:797-801.","journal-title":"Am J Cardiol"},{"key":"5477_CR13","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1111\/j.1365-2125.2010.03728.x","volume":"70","author":"WS Waring","year":"2010","unstructured":"Waring WS, Graham A, Gray J, Wilson AD, Howell C, Bateman DN. Evaluation of a QT nomogram for risk assessment after antidepressant overdose. Br J Clin Pharmacol 2010;70:881-5.","journal-title":"Br J Clin Pharmacol"},{"key":"5477_CR14","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/bcp.12040","volume":"76","author":"GK Isbister","year":"2013","unstructured":"Isbister GK, Page CB. Drug induced QT prolongation: the measurement and assessment of the QT interval in clinical practice. Br J Clin Pharmacol 2013;76:48-57.","journal-title":"Br J Clin Pharmacol"},{"key":"5477_CR15","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1093\/qjmed\/hcm072","volume":"100","author":"A Chan","year":"2007","unstructured":"Chan A, Isbister GK, Kirkpatrick CM, Dufful SB. Drug-induced QT prolongation and torsades de pointes: evaluation of a QT nomogram. Qjm 2007;100:609-15.","journal-title":"Qjm"},{"key":"5477_CR16","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1016\/j.amjcard.2019.02.057","volume":"123","author":"J Tooley","year":"2019","unstructured":"Tooley J, Ouyang D, Hadley D, et al. Comparison of QT Interval Measurement Methods and Correction Formulas in Atrial Fibrillation. Am J Cardiol 2019;123:1822-7.","journal-title":"Am J Cardiol"},{"key":"5477_CR17","first-page":"1574806","volume":"2018","author":"Y Choi","year":"2018","unstructured":"Choi Y, Lim HS, Chung D, Choi JG, Yoon D. Risk Evaluation of Azithromycin-Induced QT Prolongation in Real-World Practice. Biomed Res Int 2018;2018:1574806.","journal-title":"Biomed Res Int"},{"key":"5477_CR18","doi-asserted-by":"crossref","unstructured":"Yang Z, Prinsen JK, Bersell KR, et al. Azithromycin Causes a Novel Proarrhythmic Syndrome. Circ Arrhythm Electrophysiol 2017;10.","DOI":"10.1161\/CIRCEP.115.003560"},{"key":"5477_CR19","doi-asserted-by":"publisher","first-page":"e955","DOI":"10.1097\/MJT.0000000000000109","volume":"23","author":"NL Chang","year":"2016","unstructured":"Chang NL, Shah P, Bikkina M, Shamoon F. Clarithromycin-Induced Torsades de Pointes. Am J Ther 2016;23:e955-6.","journal-title":"Am J Ther"},{"key":"5477_CR20","first-page":"121","volume":"1","author":"WV Vieweg","year":"2013","unstructured":"Vieweg WV, Hancox JC, Hasnain M, Koneru JN, Gysel M, Baranchuk A. Clarithromycin, QTc interval prolongation and torsades de pointes: the need to study case reports. Ther Adv Infect Dis 2013;1:121-38.","journal-title":"Ther Adv Infect Dis"},{"key":"5477_CR21","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1136\/ejhpharm-2016-001077","volume":"25","author":"RB Fiets","year":"2018","unstructured":"Fiets RB, Bos JM, Donders A, et al. QTc prolongation during erythromycin used as prokinetic agent in ICU patients. Eur J Hosp Pharm Sci Pract 2018;25:118-22.","journal-title":"Eur J Hosp Pharm Sci Pract"},{"key":"5477_CR22","doi-asserted-by":"publisher","first-page":"e13302","DOI":"10.1111\/nmo.13302","volume":"30","author":"JR Giudicessi","year":"2018","unstructured":"Giudicessi JR, Ackerman MJ, Camilleri M. Cardiovascular safety of prokinetic agents: A focus on drug-induced arrhythmias. Neurogastroenterol Motil 2018;30:e13302.","journal-title":"Neurogastroenterol Motil"},{"key":"5477_CR23","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ejim.2004.03.012","volume":"15","author":"D Justo","year":"2004","unstructured":"Justo D, Mardi T, Zeltser D. Roxithromycin-induced torsades de pointes. Eur J Intern Med 2004;15:326-7.","journal-title":"Eur J Intern Med"},{"key":"5477_CR24","unstructured":"eTG complete (Therapeutic Guidelines). Therapeutic Guidelines Ltd., 2015. at \nhttp:\/\/online.tg.org.au.ezproxy.library.uq.edu.au\/ip\/desktop\/index.htm\n\n.)"},{"key":"5477_CR25","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1159\/000334441","volume":"120","author":"A Briasoulis","year":"2011","unstructured":"Briasoulis A, Agarwal V, Pierce WJ. QT prolongation and torsade de pointes induced by fluoroquinolones: infrequent side effects from commonly used medications. Cardiology 2011;120:103-10.","journal-title":"Cardiology"},{"key":"5477_CR26","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/psp4.12085","volume":"5","author":"L Kervezee","year":"2016","unstructured":"Kervezee L, Gotta V, Stevens J, et al. Levofloxacin-Induced QTc Prolongation Depends on the Time of Drug Administration. CPT Pharmacometrics Syst Pharmacol 2016;5:466-74.","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"5477_CR27","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1080\/14740338.2018.1520837","volume":"17","author":"F Khan","year":"2018","unstructured":"Khan F, Ismail M, Khan Q, Ali Z. Moxifloxacin-induced QT interval prolongation and torsades de pointes: a narrative review. Expert Opin Drug Saf 2018;17:1029-39.","journal-title":"Expert Opin Drug Saf"},{"key":"5477_CR28","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1592\/phco.21.20.1468.34482","volume":"21","author":"R Frothingham","year":"2001","unstructured":"Frothingham R. Rates of torsades de pointes associated with ciprofloxacin, ofloxacin, levofloxacin, gatifloxacin, and moxifloxacin. Pharmacotherapy 2001;21:1468-72.","journal-title":"Pharmacotherapy"},{"key":"5477_CR29","unstructured":"www.Crediblemeds.org\n\n, QTdrugs List. 2019. (Accessed June 25 2019,"},{"key":"5477_CR30","first-page":"11","volume":"2017","author":"M Salem","year":"2017","unstructured":"Salem M, Reichlin T, Fasel D, Leuppi-Taegtmeyer A. Torsade de pointes and systemic azole antifungal agents: Analysis of global spontaneous safety reports. Glob Cardiol Sci Pract 2017;2017:11.","journal-title":"Glob Cardiol Sci Pract"},{"key":"5477_CR31","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s12012-017-9403-5","volume":"17","author":"G Frommeyer","year":"2017","unstructured":"Frommeyer G, Fischer C, Ellermann C, et al. Severe Proarrhythmic Potential of the Antiemetic Agents Ondansetron and Domperidone. Cardiovasc Toxicol 2017;17:451-7.","journal-title":"Cardiovasc Toxicol"},{"key":"5477_CR32","doi-asserted-by":"crossref","unstructured":"Field J, Wasilewski M, Bhuta R, et al. Effect of Chronic Domperidone Use on QT Interval: A Large Single Center Study. J Clin Gastroenterol 2019.","DOI":"10.1097\/MCG.0000000000001183"},{"key":"5477_CR33","doi-asserted-by":"crossref","unstructured":"Wu CS, Tsai YT, Tsai HJ. Antipsychotic drugs and the risk of ventricular arrhythmia and\/or sudden cardiac death: a nation-wide case-crossover study. J Am Heart Assoc 2015;4.","DOI":"10.1161\/JAHA.114.001568"},{"key":"5477_CR34","first-page":"389","volume":"17","author":"YG Yap","year":"2002","unstructured":"Yap YG, Camm AJ. Potential cardiac toxicity of H1-antihistamines. Clin Allergy Immunol 2002;17:389-419.","journal-title":"Clin Allergy Immunol"},{"key":"5477_CR35","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jccase.2015.06.002","volume":"12","author":"A Shah","year":"2015","unstructured":"Shah A, Yousuf T, Ziffra J, Zaidi A, Raghuvir R. Diphenhydramine and QT prolongation - A rare cardiac side effect of a drug used in common practice. J Cardiol Cases 2015;12:126-9.","journal-title":"J Cardiol Cases"},{"key":"5477_CR36","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00228-014-1804-9","volume":"71","author":"J Vigne","year":"2015","unstructured":"Vigne J, Alexandre J, Fobe F, et al. QT prolongation induced by hydroxyzine: a pharmacovigilance case report. Eur J Clin Pharmacol 2015;71:379-81.","journal-title":"Eur J Clin Pharmacol"},{"key":"5477_CR37","doi-asserted-by":"publisher","first-page":"182","DOI":"10.5114\/pdia.2014.43191","volume":"31","author":"A Olasi\u0144ska-Wi\u015bniewska","year":"2014","unstructured":"Olasi\u0144ska-Wi\u015bniewska A, Olasi\u0144ski J, Grajek S. Cardiovascular safety of antihistamines. Postepy Dermatol Alergol 2014;31:182-6.","journal-title":"Postepy Dermatol Alergol"},{"key":"5477_CR38","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1001\/archinte.167.22.2469","volume":"167","author":"EF Wedam","year":"2007","unstructured":"Wedam EF, Bigelow GE, Johnson RE, Nuzzo PA, Haigney MC. QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial. Arch Intern Med 2007;167:2469-75.","journal-title":"Arch Intern Med"},{"key":"5477_CR39","doi-asserted-by":"crossref","unstructured":"Taylor D PC, Kapur S. The Maudsley Prescribing Guidelines in Psychiatry (12th ed). Hoboken, USA: Wiley; 2015.","DOI":"10.1201\/b21605"},{"key":"5477_CR40","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.psym.2017.10.009","volume":"59","author":"SR Beach","year":"2018","unstructured":"Beach SR, Celano CM, Sugrue AM, et al. QT Prolongation, Torsades de Pointes, and Psychotropic Medications: A 5-Year Update. Psychosomatics 2018;59:105-22.","journal-title":"Psychosomatics"},{"key":"5477_CR41","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1177\/0004867415617657","volume":"49","author":"GS Malhi","year":"2015","unstructured":"Malhi GS, Bassett D, Boyce P, et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Aust N Z J Psychiatry 2015;49:1087-206.","journal-title":"Aust N Z J Psychiatry"},{"key":"5477_CR42","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1007\/s00213-017-4685-7","volume":"234","author":"A Ojero-Senard","year":"2017","unstructured":"Ojero-Senard A, Benevent J, Bondon-Guitton E, et al. A comparative study of QT prolongation with serotonin reuptake inhibitors. Psychopharmacology (Berl) 2017;234:3075-81.","journal-title":"Psychopharmacology (Berl)"},{"key":"5477_CR43","doi-asserted-by":"crossref","unstructured":"Spindelegger CJ, Papageorgiou K, Grohmann R, et al. Cardiovascular adverse reactions during antidepressant treatment: a drug surveillance report of German-speaking countries between 1993 and 2010. Int J Neuropsychopharmacol 2015;18.","DOI":"10.1093\/ijnp\/pyu080"},{"key":"5477_CR44","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1177\/1060028018769425","volume":"52","author":"EM Stock","year":"2018","unstructured":"Stock EM, Zeber JE, McNeal CJ, Banchs JE, Copeland LA. Psychotropic Pharmacotherapy Associated With QT Prolongation Among Veterans With Posttraumatic Stress Disorder. Ann Pharmacother 2018;52:838-48.","journal-title":"Ann Pharmacother"},{"key":"5477_CR45","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jelectrocard.2004.07.001","volume":"37","author":"T Sadanaga","year":"2004","unstructured":"Sadanaga T, Sadanaga F, Yao H, Fujishima M. Abnormal QT prolongation and psychotropic drug therapy in psychiatric patients: significance of bradycardia-dependent QT prolongation. J Electrocardiol 2004;37:267-73.","journal-title":"J Electrocardiol"},{"key":"5477_CR46","doi-asserted-by":"publisher","first-page":"26","DOI":"10.5811\/westjem.2011.9.6866","volume":"13","author":"MP Wilson","year":"2012","unstructured":"Wilson MP, Pepper D, Currier GW, Holloman GH, Jr., Feifel D. The psychopharmacology of agitation: consensus statement of the american association for emergency psychiatry project Beta psychopharmacology workgroup. West J Emerg Med 2012;13:26-34.","journal-title":"West J Emerg Med"},{"key":"5477_CR47","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","volume":"382","author":"S Leucht","year":"2013","unstructured":"Leucht S, Cipriani A, Spineli L, et al. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet 2013;382:951-62.","journal-title":"Lancet"},{"key":"5477_CR48","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1177\/0004867416641195","volume":"50","author":"C Galletly","year":"2016","unstructured":"Galletly C, Castle D, Dark F, et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders. Aust N Z J Psychiatry 2016;50:410-72.","journal-title":"Aust N Z J Psychiatry"},{"key":"5477_CR49","unstructured":"www.Crediblemeds.org\n\n, QTdrugs List,. 2019. (Accessed June 27 2019, at \nwww.Crediblemeds.org\n\n,.)"},{"key":"5477_CR50","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-121-7-199410010-00009","volume":"121","author":"SH Hohnloser","year":"1994","unstructured":"Hohnloser SH, Klingenheben T, Singh BN. Amiodarone-associated proarrhythmic effects. A review with special reference to torsade de pointes tachycardia. Ann Intern Med 1994;121:529-35.","journal-title":"Ann Intern Med"},{"key":"5477_CR51","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.jelectrocard.2018.08.035","volume":"51","author":"G Li","year":"2018","unstructured":"Li G, Zhang L. The role of mexiletine in the management of long QT syndrome. J Electrocardiol 2018;51:1061-5.","journal-title":"J Electrocardiol"},{"key":"5477_CR52","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s11864-019-0657-y","volume":"20","author":"S Chandrasekhar","year":"2019","unstructured":"Chandrasekhar S, Fradley MG. QT Interval Prolongation Associated With Cytotoxic and Targeted Cancer Therapeutics. Curr Treat Options Oncol 2019;20:55.","journal-title":"Curr Treat Options Oncol"},{"key":"5477_CR53","doi-asserted-by":"publisher","first-page":"210","DOI":"10.2174\/1574884713666180223123947","volume":"12","author":"CV Etchegoyen","year":"2017","unstructured":"Etchegoyen CV, Keller GA, Mrad S, Cheng S, Di Girolamo G. Drug-induced QT Interval Prolongation in the Intensive Care Unit. Curr Clin Pharmacol 2017;12:210-22.","journal-title":"Curr Clin Pharmacol"},{"key":"5477_CR54","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1093\/bja\/aet412","volume":"112","author":"C Staikou","year":"2014","unstructured":"Staikou C, Stamelos M, Stavroulakis E. Impact of anaesthetic drugs and adjuvants on ECG markers of torsadogenicity. Br J Anaesth 2014;112:217-30.","journal-title":"Br J Anaesth"},{"key":"5477_CR55","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1161\/01.CIR.86.5.1439","volume":"86","author":"M Viitasalo","year":"1992","unstructured":"Viitasalo M, Karjalainen J. QT intervals at heart rates from 50 to 120 beats per minute during 24-hour electrocardiographic recordings in 100 healthy men. Effects of atenolol. Circulation 1992;86:1439-42.","journal-title":"Effects of atenolol. Circulation"},{"issue":"Suppl","key":"5477_CR56","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jelectrocard.2004.08.030","volume":"37","author":"S Luo","year":"2004","unstructured":"Luo S, Michler K, Johnston P, Macfarlane PW. A comparison of commonly used QT correction formulae: the effect of heart rate on the QTc of normal ECGs. J Electrocardiol 2004;37 Suppl:81-90.","journal-title":"J Electrocardiol"}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-019-05477-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11606-019-05477-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-019-05477-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,25]],"date-time":"2020-10-25T00:03:10Z","timestamp":1603584190000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11606-019-05477-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,25]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["5477"],"URL":"https:\/\/doi.org\/10.1007\/s11606-019-05477-7","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,25]]},"assertion":[{"value":"2 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they do not have a conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}